Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-29, Stock:JNJ, The news for the past five days is as follows:
2018-08-22: NEWS1: Jim Cramer: What Does Politics Have to Do With Johnson & Johnson's P/E?.NEWS2: Cramer: Michael Cohen plea and Paul Manafort verdict could have mixed effects on the market.NEWS3: Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal.NEWS4: Missouri judge affirms $4.69 billion talc verdict, Johnson & Johnson vows to appeal.NEWS5: Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal.NEWS6: Pacira (PCRX) Rides High on Robust Exparel Performance.NEWS7: Pacira (PCRX) Rides High on Robust Exparel Performance.NEWS8: VIVUS' (VVUS) Qsymia Falters in a Highly Competitive Market.NEWS9: VIVUS' (VVUS) Qsymia Falters in a Highly Competitive Market.NEWS10: Boost Your Portfolio’s Yield by 400% Overnight.NEWS11: Boost Your Portfolio’s Yield by 400% Overnight.NEWS12: 5 Top Stock Trades for Wednesday — How to Trade Kohl’s Earnings Rally.NEWS13: 5 Top Stock Trades for Wednesday — How to Trade Kohl’s Earnings Rally.
2018-08-23: NEWS1: Will Johnson & Johnson (NYSE:JNJ) Continue To Underperform Its Industry?.NEWS2: Analyzing Stryker’s Product Performance.NEWS3: Analyzing Stryker’s Top Line Trend.NEWS4: J&J to Appeal as Judge Confirms Jury Order in Talc Case.NEWS5: J&J to Appeal as Judge Confirms Jury Order in Talc Case.NEWS6: Roche: Recent Developments and Analysts’ Ratings in August.NEWS7: Caldwell Cassady & Curry Helps Acantha Win $8.2 Million Patent Infringement Verdict Against Medical Device Giant DePuy Synthes.NEWS8: Ex-Dividend Reminder: Core Mark Holding, Johnson & Johnson and S&P Global.NEWS9: Ex-Dividend Reminder: Core Mark Holding, Johnson & Johnson and S&P Global.NEWS10: J&J to Appeal as Judge Confirms Jury Order in Talc Case.NEWS11: Large-Cap Pharma Rebounds: 2 Stocks to Boost Your Portfolio.
2018-08-24: NEWS1: Noteworthy Friday Option Activity: JNJ, USB, VLO.NEWS2: Noteworthy Friday Option Activity: JNJ, USB, VLO.NEWS3: Top Research Reports for Johnson & Johnson, NIKE & BP.NEWS4: Top Research Reports for Johnson & Johnson, NIKE & BP.NEWS5: Top Research Reports for Johnson & Johnson, NIKE & BP.NEWS6: 3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?.NEWS7: 3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?.NEWS8: TransEnterix Expected to Report Solid Rise in Revenues in 2018.NEWS9: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018.NEWS10: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018.NEWS11: An Overview of Roche’s Hemato-Oncology Drugs MabThera and Gazvya.NEWS12: 3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?.NEWS13: What Analysts Recommend for TransEnterix and Peers in August 2018.NEWS14: What Does Stryker’s Valuation Trend Indicate?.
2018-08-27: NEWS1: Health Care Sector Update for 08/27/2018: CNC,WMGI,JNJ,PFE.NEWS2: Health Care Sector Update for 08/27/2018: CNC,WMGI,JNJ,PFE.NEWS3: UPDATE: Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business.NEWS4: Health Care Sector Update for 08/27/2018: WMGI,JNJ,PFE.NEWS5: Health Care Sector Update for 08/27/2018: WMGI,JNJ,PFE.NEWS6: Geron Stock Rose 32% in Week Ended August 24.NEWS7: Has Geron Corporation's Stock Been De-Risked?.NEWS8: Has Geron Corporation's Stock Been De-Risked?.NEWS9: Dow Movers: PFE, CAT.NEWS10: Dow Movers: PFE, CAT.NEWS11: Wall Street&apos;s latest bull run: The Greater Philadelphia public companies driving the rising tide.NEWS12: This Company Proves That Thinking Small Can Pay Off Big.NEWS13: Has Geron Corporation&apos;s Stock Been De-Risked?.NEWS14: Sympathy Move: Portola Upgraded After Competitor Reports Sour Data.NEWS15: Johnson & Johnson to Participate in the 2018 Morgan Stanley 16th Annual Global Healthcare Conference.NEWS16: The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, BP, eBay and BCE.NEWS17: The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, BP, eBay and BCE.NEWS18: The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, BP, eBay and BCE.NEWS19: Stocks making the biggest move premarket: TSLA, UAL, TWTR, NFLX & more.NEWS20: Stocks making the biggest move premarket: TSLA, UAL, TWTR, NFLX & more.NEWS21: Johnson & Johnson May Rise 9% on Better Growth.NEWS22: Johnson & Johnson to Host Investor Conference Call on the Phase 3 MARINER and COMMANDER HF Studies for XARELTO®.NEWS23: Bayer, J&J's bid to further widen use of Xarelto hits snag.
2018-08-28: NEWS1: Bayer's Blood Thinner Xarelto Fails in Line Extension Studies.NEWS2: Bayer's Blood Thinner Xarelto Fails in Line Extension Studies.NEWS3: New Rules for This Market: Cramer's 'Mad Money' Recap (Tues. 8/28/18).NEWS4: 3 ETFs for Johnson & Johnson's Healthy Breakout.NEWS5: Why Yum China Holdings, Brooks Automation, and Geron Jumped Today.NEWS6: Why Yum China Holdings, Brooks Automation, and Geron Jumped Today.NEWS7: Bayer&apos;s Blood Thinner Xarelto Fails in Line Extension Studies.NEWS8: AFMD Notches Triple-digit Gains, AXSM Strides Ahead, GERON Abuzz.NEWS9: AFMD Notches Triple-digit Gains, AXSM Strides Ahead, GERON Abuzz.NEWS10: Why Yum China Holdings, Brooks Automation, and Geron Jumped Today.NEWS11: Novartis’s Business Segments in Q2 2018.NEWS12: Why Geron Corporation's Stock Is Charging Higher Today.NEWS13: Why Geron Corporation's Stock Is Charging Higher Today.NEWS14: Why Ionis Pharmaceuticals Stock Is Plummeting Today.NEWS15: 25 Dividend Stocks That Analysts Love the Most.NEWS16: AbbVie's Imbruvica Combo Gets FDA Nod for Rare Lymphoma.NEWS17: AbbVie's Imbruvica Combo Gets FDA Nod for Rare Lymphoma.NEWS18: Dow Movers: JNJ, DWDP.NEWS19: Dow Movers: JNJ, DWDP.NEWS20: Why Geron Corporation&apos;s Stock Is Charging Higher Today.NEWS21: QUAL, JNJ, V, XOM: Large Inflows Detected at ETF.NEWS22: QUAL, JNJ, V, XOM: Large Inflows Detected at ETF.NEWS23: Novartis’s Valuation in August.NEWS24: Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron.NEWS25: Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron.NEWS26: AbbVie&apos;s Imbruvica Combo Gets FDA Nod for Rare Lymphoma.NEWS27: Johnson & Johnson Is Hiring -- and It&apos;s Ginormous News for Geron.NEWS28: [$$] Big pharma takes a gamble on NHS experiment.NEWS29: [$$] Healthcare costs: Britain’s NHS partners with big pharma.

Answer: Rise